| Identification | More | [Name]
2-Fluoro-3-(trifluoromethyl)aniline | [CAS]
123973-25-1 | [Synonyms]
2-FLUORO-3-(TRIFLUOROMETHYL)ANILINE
3-AMINO-2-FLUOROBENZOTRIFLUORIDE
ALPHA,ALPHA,ALPHA,2-TETRAFLUORO-M-TOLUIDINE
BUTTPARK 45\01-71
3-Amino-2-fluorobenzotrifluoride, 97% (2-Fluoro-3-(trifluoromethyl)aniline)
3-Amino-2-fluorobenzotrifluoride 98%
3-Amino-2-fluorobenzotrifluoride98%
2-FLUORO-3-(TRIFLUOROMETHYL)ANILINE 98%
3-Amino-2-fluorobenzotrifluoride, α,α,α,2-Tetrafluoro-m-toluidine | [Molecular Formula]
C7H5F4N | [MDL Number]
MFCD00061241 | [Molecular Weight]
179.11 | [MOL File]
123973-25-1.mol |
| Chemical Properties | Back Directory | [Appearance]
clear yellow liquid | [Boiling point ]
189 °C (lit.) | [density ]
1.39 g/mL at 25 °C(lit.)
| [refractive index ]
n20/D 1.462(lit.)
| [Fp ]
180 °F
| [storage temp. ]
Keep in dark place,Inert atmosphere,2-8°C | [solubility ]
Chloroform (Sparingly), Methanol (Slightly) | [form ]
Oil | [pka]
1.98±0.10(Predicted) | [color ]
Colourless | [Specific Gravity]
1.390 | [InChI]
InChI=1S/C7H5F4N/c8-6-4(7(9,10)11)2-1-3-5(6)12/h1-3H,12H2 | [InChIKey]
YKPDYPPZLUZONK-UHFFFAOYSA-N | [SMILES]
C1(N)=CC=CC(C(F)(F)F)=C1F | [CAS DataBase Reference]
123973-25-1(CAS DataBase Reference) |
| Safety Data | Back Directory | [Hazard Codes ]
Xn,Xi | [Risk Statements ]
R20/21/22:Harmful by inhalation, in contact with skin and if swallowed .
R36/37/38:Irritating to eyes, respiratory system and skin . | [Safety Statements ]
S26:In case of contact with eyes, rinse immediately with plenty of water and seek medical advice .
S36/37/39:Wear suitable protective clothing, gloves and eye/face protection . | [RIDADR ]
PG3 | [WGK Germany ]
3
| [Hazard Note ]
Harmful/Irritant | [HazardClass ]
6.1 | [HazardClass ]
IRRITANT | [HS Code ]
29214300 |
| Hazard Information | Back Directory | [Chemical Properties]
clear yellow liquid | [Uses]
2-Fluoro-3-(trifluoromethyl)aniline is a buliding block for various inhibitors such as 5,6,7-Trimethoxy-N-phenyl(ethyl)-4-aminoquinazoline derivatives that have anticancer activities and N-[3-(Phenylcarbamoyl)aryl]pyrimidine-5-carboxamide that are lymphocyte-specific kinase inhibitors. |
|
|